NOT-RM-25-003: Notice of Participation of the Environmental Protection Agency in RFA-RM-24-010: Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)

Notice of Participation of the Environmental Protection Agency in RFA-RM-24-010: Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)

Notice Number:

NOT-RM-25-003

Key Dates

Release Date:

January 17, 2025

Related Announcements

December 10, 2024 - Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional). See NOFO RFA-RM-24-010.

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

The Notice informs potential applicants that the U.S. Environmental Protection Agency (EPA) is participating, effective immediately, in the notice of funding opportunity (NOFO), RFA-RM-24-010, Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional). Changes to the NOFO are shown below.

The following section of RFA-RM-24-010 was modified:

Part I. Overview Information

Participating Organization(s)

Currently Reads:

National Institutes of Health (NIH)

Modified to Read (changes shown in bold italics):

National Institutes of Health (NIH)

U.S. Environmental Protection Agency (EPA)

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Complement-ARIE@od.nih.gov